ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $731,000 | +35.1% | 367,062 | +125.5% | 0.00% | – |
| Q1 2021 | $541,000 | -16.5% | 162,801 | -0.0% | 0.00% | – |
| Q4 2020 | $648,000 | +57.7% | 162,804 | +4.3% | 0.00% | – |
| Q3 2020 | $411,000 | -13.3% | 156,106 | -0.1% | 0.00% | – |
| Q2 2020 | $474,000 | +59.1% | 156,295 | +2.9% | 0.00% | – |
| Q1 2020 | $298,000 | -73.5% | 151,890 | -0.7% | 0.00% | -100.0% |
| Q4 2019 | $1,126,000 | +64.6% | 152,932 | +1.2% | 0.00% | – |
| Q3 2019 | $684,000 | -46.9% | 151,125 | +17.0% | 0.00% | -100.0% |
| Q2 2019 | $1,288,000 | -4.2% | 129,169 | +12.3% | 0.00% | 0.0% |
| Q1 2019 | $1,344,000 | -5.2% | 115,051 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $1,418,000 | -24.9% | 118,024 | +6.6% | 0.00% | 0.0% |
| Q3 2018 | $1,887,000 | +0.7% | 110,734 | +0.9% | 0.00% | 0.0% |
| Q2 2018 | $1,874,000 | – | 109,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,950,949 | $1,092,000 | 0.45% |
| AMERICAN FINANCIAL GROUP INC | 1,480,000 | $829,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 158,900 | $86,000 | 0.06% |
| Atom Investors LP | 113,151 | $63,000 | 0.03% |
| Nantahala Capital Management | 774,767 | $434,000 | 0.02% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,173,000 | 0.02% |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $659,000 | 0.01% |
| Altshuler Shaham Ltd | 1,088,848 | $609,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 309,400 | $173,000 | 0.00% |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $328,000 | 0.00% |